Kusurinomadoguchi, Inc. (JP:5592)
:5592
5592 Stock Chart & Stats
¥2661.00
-¥9.00(-0.63%)
At close: 4:00 PM EST
¥2661.00
-¥9.00(-0.63%)
Day’s Range― - ―
52-Week Range¥1,677.00 - ¥4,685.00
Previous CloseN/A
Volume47.70K
Average Volume (3M)73.92K
Market Cap
¥29.14B
Enterprise Value¥27.06B
Total Cash (Recent Filing)¥1.89B
Total Debt (Recent Filing)¥56.01M
Price to Earnings (P/E)15.0
Beta0.74
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.03%
Share Statistics
EPS (TTM)44.36
Shares Outstanding11,455,582
10 Day Avg. Volume72,500
30 Day Avg. Volume73,916
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)2.65
Price to Sales (P/S)2.00
P/FCF Ratio-4.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)206.9
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthRevenue nearly doubled over three years with acceleration in 2025, indicating durable demand for the company's offerings and expanding market penetration. Such multi-year top-line growth supports scale benefits, repeatable sales capacity, and long-term investment in product and sales capabilities.
Material Margin ImprovementSubstantial margin expansion across gross, EBIT and EBITDA suggests improving unit economics and operating leverage. If sustained, higher margins enhance cash generation potential, competitive pricing flexibility, and reinvestment capacity, underpinning stronger long-term profitability even in slower revenue periods.
Conservative Capital Structure (Current)Very low reported leverage and strong return on equity provide financial flexibility to absorb shocks, fund growth, and avoid costly external financing. A conservative capital structure increases resilience against cyclical downturns and supports strategic investments or M&A over the medium term.
Bears Say
Severe Cash Flow DeteriorationDespite reported net income, operating and free cash flow turned deeply negative in 2025, indicating earnings are not converting to cash. This undermines sustainable funding for capex, dividends, or working capital and may force external financing or asset sales, weakening medium-term financial stability.
Balance Sheet Volatility & Asset ContractionLarge year-to-year swings in assets and leverage signal balance-sheet instability and potential one-off adjustments. Such volatility complicates forecasting, raises refinancing and counterparty risks, and suggests operational or accounting shifts that could impair the company's ability to deliver consistent long-term performance.
Profitability May Be Driven By Non-Recurring ItemsManagement's clarification separating one-off implementation revenue from recurring income highlights that the 2025 profit surge may include non-recurring elements. If margins are partly driven by one-offs, durable earnings power and future margin sustainability are uncertain absent conversion to recurring cash flows.
Kusurinomadoguchi, Inc. News
5592 FAQ
What was Kusurinomadoguchi, Inc.’s price range in the past 12 months?
Kusurinomadoguchi, Inc. lowest stock price was ¥1677.00 and its highest was ¥4685.00 in the past 12 months.
What is Kusurinomadoguchi, Inc.’s market cap?
Kusurinomadoguchi, Inc.’s market cap is ¥29.14B.
When is Kusurinomadoguchi, Inc.’s upcoming earnings report date?
Kusurinomadoguchi, Inc.’s upcoming earnings report date is May 20, 2026 which is in 52 days.
How were Kusurinomadoguchi, Inc.’s earnings last quarter?
Kusurinomadoguchi, Inc. released its earnings results on Feb 13, 2026. The company reported ¥44.36 earnings per share for the quarter, beating the consensus estimate of N/A by ¥44.36.
Is Kusurinomadoguchi, Inc. overvalued?
According to Wall Street analysts Kusurinomadoguchi, Inc.’s price is currently Overvalued.
Does Kusurinomadoguchi, Inc. pay dividends?
Kusurinomadoguchi, Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 1.03%. See more information on Kusurinomadoguchi, Inc. dividends here
What is Kusurinomadoguchi, Inc.’s EPS estimate?
Kusurinomadoguchi, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kusurinomadoguchi, Inc. have?
Kusurinomadoguchi, Inc. has 11,455,582 shares outstanding.
What happened to Kusurinomadoguchi, Inc.’s price movement after its last earnings report?
Kusurinomadoguchi, Inc. reported an EPS of ¥44.36 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.572%.
Which hedge fund is a major shareholder of Kusurinomadoguchi, Inc.?
Currently, no hedge funds are holding shares in JP:5592
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kusurinomadoguchi, Inc.
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.